Obermatt

GVS

MIL:GVS · IT0005411209
Health Care Equipment & SuppliesMedium

360

39
EV / EBIT50
Price / Owner Earnings7
Owner Earnings Yield61
Dividend Yield34
Price/Sales57
EV / Gross Profit41
Price/Book70
Return on Capital81
Cash Return on Capital59
Return on Equity69
EBIT Margin86
Gross Profitability20
Cash Conversion70
Accruals41
Owner Earnings Margin59
Sales growth36
Profit Growth27
Long-Term EPS Growth25
Reinvestment1
Price momentum54
Debt load43
Refinancing35
Debt Payback5
Liquidity98
Analyst ratings62
Opinion Changes50
Price Target Upside30
Market mood50
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

GVS clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryItaly
IndustryHealth Care Equipment & Supplies
SizeMedium
TypePublic Company
ExchangeBIT
Employees569
Websitegvs.com
ISINIT0005411209
Last UpdateApr 2, 2026
Index & Theme
Water PurificationEnvironmental EngineeringHealth DiagnosticsSensorsEnvironment, Health and Safety (EH&S)Pollution ControlDetectors, Sensors and MemsRespiratoryBiomedical EngineeringHealth CareLogisticsManufacturingTransportation

Description

GVS S.p.A. is specializing in the production and development of advanced filtration devices and technologies. It operates in the medical, pharmaceutical, and industrial sectors, providing innovative solutions across various applications. Business Se…

Analysis

Middle-of-the-road

GVS S.p.A. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is expensive. The owner-earnings multiple stands at 92.5×; owner earnings: the cash an owner could take out each year.

Growth is moderate; the safety picture is adequate. The company scores 12/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
15
2023202420252026

All-time high

43

Mar 2026

All-time low

15

Jun 2026

Average rank

29

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
57
27
25
15
Price/Earnings
59
48
25
29
Price/Book
70
44
43
20
Dividend Yield
34
48
1
41
Value (overall)
52
41
16
21

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare GVS with its peers
Steris
NYQ:STE
63
CountryIreland
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Siemens Healthineers
GER:SHL
17
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Getinge
STO:GETI B
63
CountrySweden
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
First Sensor
GER:SIS
80
CountryIreland
IndustrySemiconductors & Semiconductor Equipment
SizeSmall
Full Stock Analysis →
BMW
GER:BMW
26
CountryGermany
IndustryAutomobiles
SizeXX-Large
Full Stock Analysis →
medmix
SWX:MEDX
54
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →